New York, NY - Serum levels of complement factors C3 and C4 were predictors of stroke risk over two years in a cohort of men referred for coronary angiography, with C4 emerging as predictive ...
HIGH POINT, N.C.--(BUSINESS WIRE)--High Point Clinical Trial Center (HPCTC) and Amyndas Pharmaceuticals jointly announce the completion of the AMY-101 First in Human (FIH) study, which assessed safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback